Professional US stock economic sensitivity analysis and beta calculations to understand market correlation and portfolio risk exposure to market movements. We help you position your portfolio appropriately based on your risk tolerance and overall market outlook and expectations. We provide beta analysis, sensitivity testing, and correlation to market factors for comprehensive risk assessment. Understand risk exposure with our comprehensive sensitivity analysis and beta calculations for better portfolio construction.
As of 2026-04-20, Tempest Therapeutics Inc. (TPST) trades at a current price of $1.91, marking a 2.55% decline for the current session. This analysis examines near-term technical levels, broader market context for the biotech sector, and potential price scenarios for TPST in upcoming sessions. No recent earnings data is available for the firm as of this writing, so market activity is currently being driven primarily by technical trading patterns and broader sector sentiment, rather than quarterl
Tempest Therapeutics (TPST) Stock: Why Spinoff Value (Tick Down) 2026-04-20 - Reversal Picks
TPST - Stock Analysis
3952 Comments
1489 Likes
1
Chaysen
Insight Reader
2 hours ago
Thanks for this update, the outlook section is very useful.
👍 176
Reply
2
Siranthony
Power User
5 hours ago
Indices continue to trend within their upward channels.
👍 123
Reply
3
Solida
New Visitor
1 day ago
This would’ve been really useful earlier today.
👍 171
Reply
4
Catilin
Insight Reader
1 day ago
That was ridiculously good. 😂
👍 218
Reply
5
Joia
Active Contributor
2 days ago
Indices remain in a consolidation zone, providing potential opportunities for range-bound traders.
👍 58
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.